- Half Year 2024 Idorsia Ltd Earnings Call TranscriptJul 25, 2024CHF2.74 (+18.17%)Earnings
- Idorsia Ltd to Discuss the TRYVIO FDA Approval TranscriptMar 20, 2024
- Idorsia Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Idorsia Ltd Earnings Call TranscriptOct 24, 2023CHF1.62 (-13.10%)Earnings
- Half Year 2023 Idorsia Ltd Earnings Call TranscriptJul 25, 2023CHF6.43 (-5.72%)Earnings
- Sosei Group Corp to Acquire Idorsia Ltd Pharmaceuticals Business in Japan and APAC TranscriptJul 20, 2023
- Q1 2023 Idorsia Ltd Earnings Call TranscriptApr 25, 2023CHF8.99 (-6.98%)Earnings
- Full Year 2022 Idorsia Ltd Earnings Call TranscriptFeb 07, 2023CHF12.51 (-8.89%)Earnings
- Idorsia Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Idorsia Ltd Cenerimod Phase 3 Initiation Webcast TranscriptDec 15, 2022
- Idorsia Ltd Conference Call TranscriptNov 08, 2022
- Q3 2022 Idorsia Ltd Earnings Call TranscriptOct 25, 2022CHF13.95 (+3.95%)Earnings
- Half Year 2022 Idorsia Ltd Earnings Call TranscriptJul 26, 2022CHF11.42 (+0.62%)Earnings
- Idorsia Ltd To Discuss PRECISION top-line results TranscriptMay 24, 2022
- Full Year 2021 Idorsia Ltd Earnings Call TranscriptFeb 08, 2022CHF19.88 (-4.70%)Earnings
- Idorsia Ltd To Discuss Daridorexant Phase 3 program published in The Lancet Neurology Call TranscriptJan 20, 2022
- Idorsia Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Half Year 2021 Idorsia Ltd Earnings Call TranscriptJul 27, 2021CHF24.6 (-1.99%)Earnings
- Idorsia Ltd To Discuss Phase 3 Program -Corporate Call TranscriptJun 28, 2021
- Idorsia Ltd - Pre Recorded Special Call TranscriptMar 10, 2021
- Full Year 2020 Idorsia Ltd Earnings Call TranscriptFeb 04, 2021CHF26.68 (-1.11%)Earnings
- Idorsia Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Half Year 2020 Idorsia Ltd Earnings Call TranscriptJul 23, 2020CHF26.6 (+0.23%)Earnings
- Idorsia Ltd - Special Call TranscriptJul 06, 2020
- Idorsia Ltd - Special Call TranscriptApr 20, 2020
- Full Year 2019 Idorsia Ltd Earnings Call TranscriptFeb 06, 2020CHF32.23 (-1.26%)Earnings
- Half Year 2019 Idorsia Ltd Earnings Call TranscriptJul 23, 2019CHF21.39 (-7.52%)Earnings
Idorsia Ltd Cenerimod Phase 3 Initiation Webcast Transcript
Good day, and thank you for standing by. Welcome to the cenerimod Phase 3 Initiation Webcast. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Andrew Weiss. Please go ahead.
Thank you, operator. Good afternoon, good morning to you all. My name is Andrew Weiss. I'm the Head of Investor Relations and Corporate Communications here at Idorsia. I want to welcome everyone to our webcast to discuss the initiation of the Phase 3 program investigating cenerimod for the treatment of systemic lupus erythematosus, which we announced this morning.
With me on the call here in Allschwil are our Chief Scientific Officer, Martine Clozel; and Alberto Gimona, our Head of Global Clinical Development.
Next slide, please. As customary to these calls, we will be making forward-looking statements. You have therefore been appropriately warned about the risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)